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Abstract
Sequence-based typing (SBT) combined with monoclonal antibody subgrouping of Legionella pneumophila isolates is at present considered to
be the reference standard during epidemiological investigation of Legionnaires’ disease outbreaks. In some isolates of L. pneumophila, the
seventh allele of the standard SBT scheme, neuA, is not ampliﬁed, because a homologue that is refractory to ampliﬁcation with the standard
neuA primers is present. Consequently, a complete seven-allele proﬁle, and hence a sequence type, cannot be obtained. Subsequently,
primers were designed to amplify both neuA and the homologue, but these yielded suboptimal sequencing results. In this study, novel
primers speciﬁc for the neuA homologue were designed and internationally validated by members of the ESCMID Study Group for
Legionella Infections at national and regional Legionella reference laboratories with a modiﬁed version of the online L. pneumophila sequence
quality tool. To date, the addition of the neuAh target to the SBT protocol has allowed full typing data to be obtained for 108 isolates of 11
different serogroups, namely 1, 2, 3, 4, 5, 6, 7, 8, 10, 13, and 14, which could not previously be typed with the standard SBT neuA primers.
Further studies are necessary to determine why it is still not possible to obtain either a neuA or a neuAh allele from three serogroup 11
isolates.
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Introduction
Legionellae are natural pathogens of protozoa that can also
infect humans, causing a potentially lethal form of pneumonia
known as Legionnaires’ disease (LD). The infection is typically
acquired by inhalation of aerosols from colonized water
systems of both natural and artiﬁcial origin. In 2011, 4897 LD
cases were reported by EU member states, Iceland, and
Norway; although many different Legionella species can be
isolated from environmental sources, among 600 culture-con-
ﬁrmed LD cases, Legionella pneumophila alone caused 96% of
LD infections and serogroup 1 strains were isolated from 85%
of these [1].
During LD outbreak investigations, clinical and environ-
mental L. pneumophila isolates must be typed to identify the
source of the infection. Sequence-based typing (SBT) is the
internationally accepted typing method developed by members
of the ESCMID Study Group for Legionella Infections (ESGLI,
formerly the European Working Group for Legionella Infec-
tions). SBT consists of the DNA sequence determination of
deﬁned regions of seven genes (namely ﬂaA, pilE, asd, mip,
mompS, proA, and neuA) in order to obtain an allelic proﬁle and
a sequence type (ST) number, which are then used together
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with serogrouping and monoclonal antibody subgrouping data
to compare clinical strains with those isolated from different
environmental sources [2,3]. In some isolates, it is not possible
to amplify neuA, a gene coding for N-acylneuraminate cytidyl-
transferase, one of the enzymes involved in lipopolysaccharide
(LPS) biosynthesis [4]; consequently a complete allelic proﬁle
and an ST number cannot be obtained. Farhat et al. [5]
sequenced the LPS locus from Dallas-1E, the serogroup 5 type
strain of L. pneumophila, and showed that a variant with 68%
homology with neuA, and thus not ampliﬁed by the standard
SBT primers, is present. Degenerate primers able to amplify
and sequence both neuA and the neuA homolog (neuAh) were
described. However, when they were brought into routine
use, it was found that modiﬁcation of PCR conditions was
required for some strains, and even then suboptimal ampliﬁ-
cation and sequencing results were observed. Moreover,
degenerate primers are not recommended for direct typing on
DNA samples extracted from clinical specimens, a technique
that is becoming increasingly important during LD outbreak
investigations [6,7].
In this study, novel primers speciﬁc for neuAh were
designed and subsequently internationally validated by ESGLI
members. These primers have been shown to yield PCR
products from a wide range of different strains under the same
PCR conditions, and to give improved sequencing results in
comparison with those previously described [5]. Furthermore,
they have been used effectively in direct typing from clinical
samples.
Materials and Methods
Bacterial strains
A panel of 47 L. pneumophila strains isolated in Europe, North
America, Africa, and Australia, belonging to serogroups 2, 3, 4,
5, 6, 7, 8, 10, 11, 13, and 14, including ten type strains from the
National Collection of Type Cultures (Public Health England,
UK), that failed to give a neuA product with the standard SBT
primers were tested (Table 1). Strains belonging to the
remaining serogroups, namely 1, 9, 12, and 15, were not
included, because ampliﬁcation of the neuA target with the
standard SBT primers was always successful by the completion
of this study. Five further strains, namely EULV 2665,
EULV 3028, EULV 6671, EULV 6861, and EULV 6862
(Table 1), distributed as part of the ESGLI L. pneumophila
SBT Proﬁciency Panels between 2010 and 2012, were tested
worldwide by ESGLI members at national and regional
Legionella reference laboratories, in order to complete the
validation of the novel neuAh primers.
DNA extraction
Strains were inoculated onto buffered charcoal yeast
extract agar (Oxoid, Basingstoke, UK) and incubated at
37°C for 48–72 h in a moist atmosphere; two or three
single colonies per strain were pelleted, and genomic DNA
was extracted with the InstaGene matrix (Bio-Rad, Hercules,
CA, USA), according to the manufacturer’s instructions.
Extracted samples were centrifuged at 15 000 g for 5 min,
and the supernatant was used as a template for PCR
reactions.
Bioinformatic analysis and primer design
Nucleotide sequences of neuA (including 100 bp upstream and
downstream of the gene) of the Corby, Lens, Paris and
Philadelphia L. pneumophila serogroup 1 strains were obtained
from the LegioList database (http://genolist.pasteur.fr/LegioList/),
and that of the neuAh found in Dallas-1E, the L. pneumophila
serogroup 5 strain, was obtained from GenBank (Accession
number: FN256429). Sequences were aligned by the use of
ClustalW (www.ebi.ac.uk/Tools/msa/clustalw2/), and primers
were designed with Primer3 (http://frodo.wi.mit.edu/).
PCR assays
Ampliﬁcation was performed by PCR in a ﬁnal volume of
20 lL with 10 pmol of each primer. Two microlitres of
supernatant from InstaGene extracts was used as DNA
template, and 2 lL of DNA extracted from L. pneumophila
Dallas-1E (NCTC 11405) and 2 lL of sterile PCR-grade
water (Sigma-Aldrich, St. Louis, MO, USA), respectively, were
used as positive and negative controls in all PCR experiments.
First, 1 U of Taq DNA polymerase (Life Technologies,
Carlsbad, CA, USA) was used in a DNA Engine (MJ Research,
St. Bruno, Canada) under the following conditions: 40 cycles
of denaturation for 30 s at 95°C, annealing for 30 s at 50°C,
and elongation for 30 s at 72°C; an initial denaturation step
(5 min at 95°C) and a ﬁnal elongation step (10 min at 72°C)
were also included. Ampliﬁcation was then repeated with a
Fast PCR Mix (Life Technologies) in a Veriti thermocycler
(Life Technologies) under the following conditions: 35 cycles
of denaturation for 10 s at 95°C, annealing for 10 s at 55°C,
and elongation for 20 s at 70°C; an initial denaturation step
(1 min at 95°C) and a ﬁnal elongation step (1 min at 72°C)
were also included.
Gel electrophoresis
Two microlitres from each PCR reaction was analysed by
electrophoresis in 2% E-gels (Life Technologies), and the
results were visualized under UV light with the InGenius gel
documentation system (Syngene, Cambridge, UK).
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Sequencing
A 10-lL aliquot of each positive PCR reaction was sent
together with the relevant primers to the Genomic Services
Unit at Public Health England (London, UK). Puriﬁcation of
PCR products was performed with a magnetic bead system
(Beckman Coulter, Pasadena, CA, USA), and DNA was then
sequenced with an ABI platform (3730XL DNA Analyzer; Life
Technologies).
Sequence analysis
Trace ﬁles obtained from the Genomic Services Unit were
analysed with SeqScanner (Life Technologies), BioNumer-
ics 6.1 (Applied Maths, Sint-Martens-Latem, Belgium) and the
L. pneumophila sequence quality tool (SQT) (http://www.
hpa-bioinformatics.org.uk/cgi-bin/legionella/sbt/seq_assemble_
legionella1.cgi).
Results and Discussion
First set of primers
A ﬁrst set of primers, neuA_L (5′-CAATTCCATCCAGAA
AAAAG-3′) and neuA_R (5′-ACTCTTTGGCTGCATAAA-3′),
was designed on the basis of the alignment of the ﬁve
L. pneumophila type strains, as described earlier. These primers
were used to amplify a fragment of 858–861 bp (in some
strains, a triplet deletion was observed) containing neuAh
(699 bp in Dallas-1E) from all of the strains listed in Table 1. A
fragment of the expected size was obtained for 41 of 47
L. pneumophila strains tested. No ampliﬁcation was obtained
for H073420023 (serogroup 5), H080200574 (serogroup 10),
H112940222 (serogroup 10), 797-PA-H (serogroup 11),
LC4339 (serogroup 11), and MO-296251110 (serogroup 11).
TABLE 1. List of Legionella pneumophila strains included in this study
Strain NCTC Country Source Serogroup Allelic proﬁle ST neuAh length (bp)
H080160264 England E 2 2, 10, 4, 28, 4, 4, 207 1302 696
ZS-HK 1 (4) Czech Republic E 3 2, 10, 15, 28, 4, 3, 207 1390 696
Los Angeles-1 11233 USA C 4 11, 14, 16, 25, 7, 13, 206 1334 696
H100200318 England E 4 5, 1, 22, 30, 6, 10, 203 1324 696
H080500042 England E 4 5, 1, 22, 30, 6, 10, 203 1324 696
Dallas-1E 11405 USA E 5 11, 14, 16, 18, 15, 13, 201 1300 699
H073240536 SHIP C 5 11, 14, 16, 31, 15, 13, 210 1327 696
H073340034 SHIP C 5 11, 14, 16, 31, 15, 13, 210 1327 696
H073280012 SHIP E 5 11, 14, 16, 31, 15, 13, 210 1327 696
H073420023 SHIP E 5 20, 26, 27, 34, 46, 27, 212 1328 696
H073340593 SHIP C 5 11, 14, 16, 31, 15, 13, 210 1327 696
H042740084 England E 6 6, 10, 22, 3, 21, 3, 207 1322 696
H093620216 England E 6 2, 10, 3, 3, 9, 14, 207 1337 696
Chicago-8 11984 USA E 7 2, 6, 17, 14, 12, 8, 211 1319 696
Concord-3 11985 USA C 8 8, 1, 22, 30, 6, 10, 203 1320 696
03L113-2 Australia E 8 13, 11, 4, 9, 23, 16, 214 1321 699
H064160534-4 England E 8 5, 1, 22, 30, 6, 10, 203 1324 696
LC0569 England C 8 3, 10, 1, 28, 14, 9, 207 1326 696
LC0606 England E 8 3, 10, 1, 28, 14, 9, 207 1326 696
LC6546 England C 8 12, 8, 11, 20, 40, 12, 216 1332 696
LC0467 England C 8/10 3, 10, 1, 28, 14, 9, 207 1326 696
LC0831 England C 8/10 5, 2, 22, 10, 6, 25, 203 1358 696
LC0850 England C 8/10 3, 10, 1, 28, 14, 9, 207 1326 696
H062620006 England C 10 6, 10, 3, 28, 9, 4, 207 1323 696
H064160536-3 England E 10 7, 6, 3, 20, 13, 11, 205 1325 696
H070300486 Unknown C 10 3, 10, 1, 28, 14, 9, 207 1326 696
H080200574 England E 10 1, 4, 3, 5, 50, 1, 213 1329 699
H082960038 England E 10 22, 4, 3, 8, 1, 15, 204 1391 696
H083580006 England E 10 6, 35, 38, 42, 1, 14, 207 1336 696
H102700702 England E 10 7, 6, 17, 28, 13, 11, 207 1288 696
LC0395 Belgium E 10 2, 10, 3, 28, 9, 4, 207 1333 696
LC1132 England C 10 2, 10, 3, 28, 9, 14, 207 1333 696
LC6813 England E 10 2, 10, 3, 28, 9, 14, 207 1333 696
LC6817 England E 10 2, 10, 3, 28, 9, 14, 207 1333 696
H112940222 England C 10 2, 6, 17, 28, 13, 3, 207 1330 696
797-PA-H 12179 USA C 11 12, 17, 11, 10, 5, 12, F 0 NA
LC4339 England C 11 2, 10, 14, 28, 2, 2, F 0 NA
MO-296251110 Italy C 11 21, 27, 28, 23, 15, 29, F 0 NA
82A3105 12181 USA C 13 6, 10, 5, 10, 9, 1, 209 1318 699
LC5695 England C 13 6, 10, 14, 10, 33, 1, 209 1331 699
1586-SCT-H 12174 Scotland C 14 5, 1, 22, 30, 6, 10, 203 1324 696
1353799 South Africa E 2–14 16, 21, 12, 19, 31, 21, 215 1317 699
1353802 South Africa E 2–14 16, 21, 12, 19, 31, 21, 215 1317 699
1353819 South Africa E 2–14 16, 21, 12, 19, 31, 21, 215 1317 699
MICU-B 12271 USA E ND 14, 18, 8, 18, 28, 19, 201 1335 699
U7W 12272 USA E ND 14, 18, 8, 18, 28, 19, 201 1335 699
U8W 12273 USA E ND 14, 18, 8, 18, 28, 19, 201 1335 699
EULV 2665 England C 10 3, 10, 1, 28, 14, 9, 207 1326 696
EULV 3028 SHIP C 5 11, 14, 16, 31, 15, 13, 210 1327 696
EULV 6671 England E 10 6, 35, 38, 42, 1, 14, 207 1336 696
EULV 6861 Greece E 3 3, 13, 1, 3, 14, 9, 207 1341 696
EULV 6862 Greece E 10 3, 13, 1, 28, 14, 9, 207 1392 696
C, clinical; E, environmental; F, neuA ampliﬁcation failed with SBT primers; NA, not applicable; ND, not determined; SHIP, infection acquired when travelling on cruise ship; ST,
sequence type; Unknown, more than one country visited during the incubation period; 8/10, serogroup 8/serogroup 10 cross-reactive; 2–14, non-serogroup 1.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, O435–O441
CMI Mentasti et al. Addition of neuAh to the L. pneumophila SBT scheme O437
Second set of primers
A second set of primers, neuAh_L (5′-ATCCAGCAGTTTT
TAMAAATTTAGG-3′) and neuAh_R (5′-TGGCTGCATAA
AYTAATTCTTTAGCCA-3′), was designed internally to
neuA_L and neuA_R by use of the consensus of the neuAh
sequences obtained with the ﬁrst set of primers. The new
primers were used to amplify a fragment of 791–794 bp
containing neuAh from all of the strains listed in Table 1. A
fragment of the expected size was obtained for 44 of 47
strains. No ampliﬁcation was obtained for 797-PA-H (sero-
group 11), LC4339 (serogroup 11), and MO-296251110
(serogroup 11).
Sequence quality
The quality of the trace ﬁles obtained with the novel primers
was compared with that obtained with the primers published
by Farhat et al. by use of SeqScanner (Life Technologies). The
analysis showed a QV20+ value, deﬁned as the total number
of bases in the entire trace that have basecaller quality value
of ≥20, close to 800 when neuAh_L and neuAh_R were used,
as compared with values of <400 and <250, respectively,
when neuA_up and neuA_do2 were used (Fig. 1). Consider-
ing that 354 bp is the length of the fragment used to
determine the allele type for the neuA target, a QV20+ value
of <250 is below that necessary to obtain a good-quality
double-stranded consensus sequence across the entire allelic
region.
neuA homologue
As previously described by Farhat et al. [5] neuAh exists in at
least two variants with different lengths. In 11 of the 44 strains
(including Dallas-1E), the gene was 699 bp in length, and
encoded a protein of 232 amino acids, as in the neuA ampliﬁed
by the standard SBT primers. The GAA triplet present at
positions 499–501 in Dallas-1E (corresponding to glutamic acid
at position 167 in the encoded protein) was absent in the
remaining 33 strains (Table 1). The start codon is also distinct:
ATG in the standard neuA, and GTG in the 699-bp variant (as
in Dallas-1E), and TTG in the 696-bp variant (as in Los
Angeles-1). The fact that GTG (normally encoding valine) and
TTG (normally encoding leucine) can be used by prokaryotes
as start codons instead of ATG has been reported previ-
ously [8].
Serogroup 11
No neuA or neuAh PCR product was obtained for 797-PA-H,
LC4339, and MO-296251110. As all of these three strains
belong to serogroup 11, and they are the only serogroup 11
strains available to the authors, it was decided to investigate
this issue further. New primers, neuA_L2 (5′-GAT-
ACTTTATACGATGGTCAGCCTATTAG-3′) and neuA_R2
(5′-GCATTATTTTTTTGGTATTCCGCTTTT-3′), were
designed, this time externally to neuA_L and neuA_R, on the
basis of the alignment between the regions upstream and
downstream of Dallas-1E neuAh and the correspondent neuA
regions found in the Corby, Lens, Paris and Philadelphia strains.
Ampliﬁcation was performed as described above in a DNA
Engine (MJ Research), but with 50°C for annealing and a 90 s
extension time for 40 cycles. A PCR product of the expected
size (1017 bp) was ampliﬁed from Dallas-1E, one fragment
with a size smaller than expected (c. 800 bp) yielding weak
ﬂuorescence following electrophoretic analysis was ampliﬁed
from 797-PA-H and LC4339, and no PCR product was
obtained for MO-296251110. As expected, the sequenced
Dallas-1E fragment showed a homology of c. 73% with the
same fragment in the genome of the Paris strain according to
blastn (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The fragment
sequenced from the two serogroup 11 strains instead showed
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FIG. 1. Comparison of the QV20+ values of the neuAh trace ﬁles obtained from the Legionella pneumophila serogroup 5 Dallas-1E strain
(NCTC 11405) with the Farhat et al. [5] primers (left) and the novel primers (right).
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99% identity with the LPS locus of the Paris strain, but only at
the 3′-terminus of the sequence (Fig. 2). The rest of the
fragment showed identities of 79% and 81%, respectively, with
two other genes of the Paris strain that are not part of the LPS
locus. In order to determine whether this result was
attributable to recombination or was a simple PCR artefact,
FIG. 2. Schematic representation of the blastn analysis of the amplicons obtained with the primers neuA_L2 and neuAh_R2, and comparison with
part of the lipopolysaccharide (LPS) locus of the Paris strain of Legionella pneumophila.
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FIG. 3. ClustalW analysis of the 50 neuA allele variants and the 22 neuAh allele variants so far described.
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the DNA sequences obtained from 797-PA-H and LC4339
were translated with the Translate Tool from the ExPASy
website (http://web.expasy.org/translate). As a high number of
stop codons were found, the recombination hypothesis
appears to be more likely, because the presence of such
codons suggests that these genes are not transcribed, and are
thus free to accumulate mutations without these becoming
lethal for the bacterial cell.
Modiﬁcation of the L. pneumophila SQT
The SQT was modiﬁed to accept neuAh alleles and assign them
to the neuA locus. Homologue alleles were designated starting
from number 201, in order to differentiate them from neuA
alleles. The creation of a new table to store the neuAh alleles in
the L. pneumophila SBT database (www.hpa-bioinformatics.org.
uk/legionella/legionella_sbt/php/sbt_homepage.php) was nec-
essary, owing to the divergence of the neuAh and neuA
sequences (Fig. 3). In addition, because, to date, three allelic
length variants have been described (351, 354 and 357
nucleotides), the SQT was modiﬁed to allow for these
differences from the other loci, which have a ﬁxed length.
To date, for the neuA locus, 22 neuAh alleles (neuAh 201
to neuAh 222) have been described and stored in the
database, together with 50 neuA alleles (neuA 1 to neuA 50)
(Fig. 3).
International validation
The novel primers neuAh_L and neuAh_R were tested
worldwide by ESGLI members on ﬁve EULV strains that are
refractory to the ampliﬁcation of neuA (Table 1). Results were
submitted by 35 laboratories for EULV 6861 and EULV 6862,
by 19 laboratories for EULV 2665, and by 18 laboratories for
EULV 6671 and EULV 3028 (Table 2). The expected neuAh
allele was obtained by all testing laboratories for EULV 2665
(207), EULV 3028 (210), EULV 6671 (207), and EULV 6862
(207). EULV 6861 was correctly reported as neuAh 207 by 33
of 35 laboratories. Two laboratories erroneously obtained a
neuA (12) allele for these strains. As this allele was consistent
TABLE 2. neuAh allele results and Phred scores obtained internationally by ESCMID Study Group for Legionella Infections
(ESGLI) members on ﬁve EULV strains distributed as part of the ESGLI Legionella pneumophila SBT Proﬁciency Panel between
2010 and 2012
Laboratory
EULV 3028 EULV 6671 EULV 2665 EULV 6862 EULV 6861
neuAh
allele
Phred
score
neuAh
allele
Phred
score
neuAh
allele
Phred
score
neuAh
allele
Phred
score
neuAh
allele
Phred
score
1 NT NT NT NT NT NT NT NT NT NT
2 NT NT NT NT NT NT 207 89.49 207 86.04
3 210 90.00 207 90.00 207 90.00 207 90.00 207 90.00
5 NT NT NT NT NT NT 207 90.00 207 90.00
6 210 90.00 207 90.00 207 90.00 207 90.00 207 90.00
8 NT NT NT NT NT NT 207 90.00 207 90.00
9 NT NT NT NT NT NT 207 90.00 207 82.01
11 NT NT NT NT NT NT 207 90.00 207 90.00
12 210 89.44 207 90.00 207 90.00 207 90.00 207 90.00
14 210 90.00 207 90.00 207 90.00 207 89.92 207 90.00
15 NT NT NT NT NT NT 207 90.00 207 89.83
16 210 89.96 207 90.00 NT NT 207 90.00 207 90.00
20 210 89.87 207 90.00 207 89.99 207 89.94 207 89.99
23 210 89.25 207 90.00 207 87.38 207 90.00 207 90.00
24 210 89.84 207 88.57 207 88.82 207 88.30 207 88.24
25 210 90.00 207 90.00 207 90.00 207 90.00 207 90.00
26 NT NT NT NT NT NT NT NT NT NT
27 NT NT NT NT NT NT 207 90.00 12 NA
28 NT NT NT NT NT NT 207 90.00 207 90.00
29 210 89.93 207 88.56 207 89.31 207 84.67 207 90.00
30 210 89.70 207 90.00 207 90.00 207 90.00 207 90.00
32 210 90.00 207 90.00 207 90.00 207 86.22 207 83.04
33 210 89.99 207 90.00 NT NT 207 90.00 207 90.00
34 NT NT NT NT NT NT 207 89.99 207 90.00
35 NT NT NT NT NT NT 207 90.00 207 90.00
36 210 89.98 207 90.00 207 89.97 207 86.41 207 89.64
39 NT NT NT NT 207 90.00 207 90.00 207 90.00
40 NT NT NT NT NT NT 207 90.00 207 90.00
43 210 90.00 207 90.00 207 90.00 207 90.00 207 89.27
44 NT NT NT NT NT NT 207 90.00 12 NA
46 NT NT NT NT NT NT 207 90.00 207 90.00
47 210 90.00 207 90.00 207 90.00 207 88.23 207 90.00
48 NT NT NT NT NT NT 207 80.20 207 80.76
49 210 90.00 207 90.00 207 90.00 207 90.00 207 90.00
51 NT NT NT NT 207 90.00 207 89.98 207 89.92
52 NT NT NT NT NT NT NT NT NT NT
53 NT NT NT NT 207 90.00 207 90.00 207 90.00
54 NT NT NT NT 207 90.00 207 90.00 207 90.00
55 NT NT NT NT NT NT NT NT NT NT
NA, not applicable; NT, not tested.
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with another strain in the proﬁciency panel, this strongly
suggests a contamination event, highlighting the fact that
contamination issues can affect PCR-based typing schemes and
cause the designation of new STs from allelic proﬁles that are
not real. The two neuA (12) results were not taken into
account in the ﬁnal analysis. All participants obtained
good-quality sequences, with Phred scores ranging from
80.20 to 90.00; in most cases, the score was equal to 90.00
(80 of 125 submitted neuAh alleles) or higher than 85.00 (115
of 125 submitted neuAh alleles).
Conclusions
In this article, we describe themodiﬁcation of the internationally
standardized L. pneumophila SBT protocol in order to include
those strains of L. pneumophila for which the ampliﬁcation of
neuA is not successful because a homologue, neuAh, is present.
Novel primers speciﬁc for neuAh were shown to provide
superior results than those described previously by Farhat et al.
Longer PCR fragments (791–794 bp vs. 431–434 bp) and better
sequence quality (QV20+ c. 800 vs. <400) were obtained,
greatly facilitating the designation of the neuAh alleles.
The presence of two variants of neuAh, one of 699 bp with
GTG as the start codon and one of 696 bp with TTG as the
start codon, was conﬁrmed. In the case of all three available
serogroup 11 strains, it was not possible to obtain either a full
neuA or a full neuAh sequence. For two of these strains, i.e.
797-PA-H and LC4339, only a fragment with 99% homology in
the 3′-region with the neuA found in the Paris strain was
observed. The presence of several stop codons suggests a
possible recombination event; however, sequencing of the LPS
locus or of the whole genome should be performed in order
to conﬁrm this hypothesis. Farhat et al. did not include any
serogroup 11 strain in their analysis, so this issue was not
previously identiﬁed.
The L. pneumophila SQT was modiﬁed in order to recognize
and process neuAh trace ﬁles generated with neuAh_L and
neuAh_R, and to designate neuAh alleles starting from allele
number 201 in order to differentiate them from the neuA
alleles. The novel primers were tested worldwide by ESGLI
members at national and regional Legionella reference
laboratories with ﬁve L. pneumophila EULV strains. Following
the satisfactory results obtained during this validation study,
the novel neuAh primers have been ofﬁcially incorporated into
the SBT scheme of L. pneumophila, and are used in combination
with the modiﬁed SQT to obtain a full seven-allele SBT proﬁle,
and hence an ST, when the ampliﬁcation of neuA is not
successful with the standard SBT primers. To date, neuAh data
for 108 isolates of 11 different serogroups, namely 1, 2, 3, 4, 5,
6, 7, 8, 10, 13, and 14, comprising 22 distinct alleles, have been
submitted to the international L. pneumophila database.
Further studies are necessary to investigate why neither neuA
nor neuAh are ampliﬁed from serogroup 11 strains.
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